| 362/613 | US=14 / Radioterapia Ratanatharathorn V, Peñagarícano JA. Management of bone metastases. In: Lu JJ, Brady LW. Radiation oncology: an evidence-based approach. New York: Springer, 2008. p. 599-610. (Medical radiology: diagnosis imaging and radiation oncology series editors; AL Baert, LW Brady, HP Heilmann, Knauth M, M Molls, C Nieder) ISBN 978-3-540-77384-9. GESTAO DE METASTASES OSSEAS; TRATAMENTO DE METASTASES OSSEAS; TERAPEUTICA ESPECIAL; PACIENTES COM METASTASES OSSEAS SOLITARIAS |
| 363/613 | US=10 / Ética/Pesq Pessini L, Barchifontaine CP. Declaração sobre a produção e o uso científico e terpêutico das células estaminais embrionárias humanas. In: ___. Problemas atuais de bioética. São Paulo: Loyola, 2008. p. 745-56. ISBN 85-15-00321-1. TERAPEUTICO DAS CELULAS ESTAMINAIS EMBRIONARIAS HUMANA; CLONAGEM TERAPEUTICA |
| 364/613 | US=21 / Biol/Mol Giavazzi R, Bonezzi K, Taraboletti G. Microtubule targeting agents and the tumor vasculature. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 519-30. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0. AGENTES DE MICROTUBULOS SEGMENTACAO EA VASCULARIZACAO DO TUMOR; INIBIDORES DA ANGIOGENESE; AGENTE DE RUPTURA VASCULAR; CELULAS ENDOTELIAIS; VASCULATURA TUMORAL; TERAPEUTICA DE COMBINACAO |
| 365/613 | US=27 / Radioterapia Grunberg S. Meningioma: systemic therapy perspective. In: Chin LS, Regine WF. Principles and practice of steriotatic radiosurgery. New York: Springer, 2008. p. 271-3. ISBN 978-0-387-71069-3. |
| 366/613 | US=28 / Urologia Kansas BT, Crispen PL, Uzzo RG. The role of angioinfarction in the management of renal tumors. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 247-64. ISBN 978-1-58829-251-3. PAPEL DA ANGIOMIOLIPOMA NA GESTAO DOS TUMORES RENAIS; HIPERVASCULARIZACAO; MATERIAIS DE EMBOLIZACAO; ANGIOMIOLIPOMA TERAPEUTICA PARA O CARCINOMA DE CELULAS RENAIS; EMBOLIZACAO PARA ANGIOMIOLIPOMA |
| 367/613 | US=2 / Tórax Hanrahan EO, Nilsson M, Heymach JV. Tumor angiogenesis: biology and therapeutic implications for lung cancer. In: Roth JA, Cox JD, Hong WK, editors. Lung cancer. 3rd ed. Oxford: Blackwell Science, 2008. p. 369-85. ISBN 978-1-4051-5112-2. ANGIOGENESE TUMORAL; TERAPEUTICA PARA O CANCER DE PULMAO; ANGIOGENESE NO CANCER DE PULMAO |
| 368/613 | US=39 / Câncer Wilson TR, Longley DB, Johnston PG. Therapeutic targeting of apoptosis in cancer. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 263-78. ISBN 978-1-58829-989-5. |
| 369/613 | US=39 / Câncer Dings RPM, Klein M, Mayo KH. Non-peptidic mimetics as cancer-sensitizing agents. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 305-25. ISBN 978-1-58829-989-5. AGENTES SENSIBILIZADORES NAO-PEPTIDICOS MIMETICOS; CANCER; TERAPEUTICA DE COMBINACAO |
| 370/613 | US=3-B / Clín/Médica Bristrian BR, Driscoll DF. Nutrição enteral e parenteral terapêutica. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison medicina interna. 17ª ed. Rio de Janeiro: McGraw-Hill, 2008. p. 455-62. ISBN 85-7726050-8. NUTRICAO ENTERAL; PARENTERAL TERAPEUTICA; NUTRICAO PARENTERAL |
| 371/613 | US=211 / Mono/Enfermagem Saraiva MI. Drogas antineoplásicas no tratamento do câncer de mama associado a gravidez (PABC): uma revisão de literatura. São Paulo, 2012. 55 p. -[Monografia de Conclusão do Curso de Pós Graduação Lato Sensu Enfermagem Oncológica Fundação Antonio Prudente]. |
| 372/613 | US=49-D / Câncer Linger RMA, Keating AK, Earp HS, Graham DK. TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. In: Woude GFV, Klein G. Advances in cancer research. v.100. Amsterdam: Elsevier, 2008. p. 35-83. ISBN 978-0-12-374358-9. TAM; TIROSINA QUINASES; FUNCOES BIOLOGICAS; SINALIZACAO; TERAPEUTICA; CANCER HUMANO; BIOLOGIA MOLECULAR |
| 373/613 | US=65 / Biol/Mol Gill JH, Loadman PM. Development of tumour-selective and endoprotease-activated anticancer therapeutics. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 853-76. ISBN 978-0-387-69056-8. DESENVOLVIMENTO DE TUMORES SELETIVOS; ENDOPROTEASE ATIVADO; TERAPEUTICA ANTICANCER |
| 374/613 | US=67 / Biol/Mol Knights CD, Pestell RG. The cell cycle: therapeutic targeting of cell regulatory components and effector pathways in cancer. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 3-32. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. CICLO CELULAR; SEGMENTACAO TERAPEUTICA; COMPONENTES CELULARES; VIAS REGULADORAS; CANCER; CICLINA DEPENDENTE DE QUINASE; INIBIDORES CDK; TERAPIA; ACETILACAO; P53; CICLINA D1; EGFR; HDAC; STI-571; FLAVOPIRIDOL; INIBIDOR CDK2 |
| 375/613 | US=67 / Biol/Mol Easton JB, Houghton PJ. mTOR: properties and therapeutics. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 33-53. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. MTOR; PROPRIEDADES; TERAPEUTICA; INIBIDORES; RAPAMICINA; CANCER; ENSAIOS CLINICOS |
| 376/613 | US=67 / Biol/Mol Schwartz JD, Llovet JM. Molecular targeting in hepatocellular carcinoma. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 165-210. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. CARCINOMA HEPATOCELULAR; ALVO MOLECULAR; TERAPEUTICA ANTI-ANGIOGENESE; FATORES DE CRESCIMENTO |
| 377/613 | US=69 / Câncer Jonasch E, Tannir N. Targeted therapy in renal cell carcinoma. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 305-16. ISBN 978-1-60327-423-4. TERAPIA-ALVO; CARCINOMA DE CELULAS RENAIS; MUTACAO BVS; ANTIVASCULAR TERAPIA; TERAPEUTICA DE COMBINACAO; TERAPIA SEQUENCIAL |
| 378/613 | US=7 / Farmacologia Wells BG, DiPiro JT, Schwinghammer TL, DiPiro Cecily V. Antimicrobial regimen selection. In: ___. Pharmacotherapy handbook. 7th ed. New York: McGraw-Hill, 2008. p. 377-86. ISBN 978-0-07-148501-2. SELECAO REGIME ANTIMICROBIANO; TERAPEUTICA DE COMBINACAO ANTIMICROBIANA; FALHA DA TERAPIA ANTIMICROBIANA |
| 379/613 | US=86 / Biol/Mol Moore VDG, Letai A. Rational design of therapeutics targeting the BCL-2 family: are some cancer cells primed for death but waiting for a final push?. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 159-75. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. MORTE CELULAR; APOPTOSE; FAMILIA BCL-2; BH3; TERAPEUTICA; PEPTIDEOS |
| 380/613 | US=8-A / Dermatologia Krutmann J, Morita A. Therapeutic photomedicine: phototherapy. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2008. p. 2469-77. ISBN 978-0-07-138076-0. FOTOMEDICINA TERAPEUTICA; FOTOTERAPIA; PSORIASE; DERMATITE ATOPICA |